All News - Eli Lilly and Company
Oct 28, 2024 · Lilly's latest press releases, stories, news resources and more.
Eli Lilly stock tumbles after drug giant misses estimates and …
Oct 30, 2024 · The company’s stock closed more than 6% lower on Wednesday. Eli Lilly now expects full-year adjusted earnings of between $13.02 and $13.52 per share, down from previous guidance of $16.10 to $16 ...
Lilly reports Q3 2024 financial results highlighted by strong …
INDIANAPOLIS, Oct. 30, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced its financial results for the third quarter of 2024. "Lilly had another strong growth quarter in Q3, with total revenue increasing by 42% after excluding divestiture activity in the same period last year," said David A. Ricks , Lilly chair and CEO.
Lilly.com | Eli Lilly and Company
Press Releases. INDIANAPOLIS , Nov. 1, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced that data from the Phase 3 trial (EMBER-3) for imlunestrant, an oral selective estrogen receptor degrader (SERD), will be reported for the first time in a late-breaking oral presentation at the San Antonio.
News Release - Eli Lilly and Company
INDIANAPOLIS, May 13, 2022 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) approved Mounjaro™ (tirzepatide) injection, Eli Lilly and Company's (NYSE: LLY) new once-weekly GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptor agonist indicated as an adjunct to diet and exercise to improve ...
Lilly's mirikizumab is first and only IL23p19 antagonist to report …
Oct 28, 2024 · Omvoh and its delivery device base are trademarks owned by Eli Lilly and Company. About Lilly Lilly is a medicine company turning science into healing to make life better for people around the world. We've been pioneering life-changing discoveries for nearly 150 years, and today our medicines help tens of millions of people across the globe.
Lilly hits record high after Mounjaro fuels forecast raise, rival data
Aug 8, 2023 · Eli Lilly on Tuesday raised its annual forecasts as demand for new diabetes drug Mounjaro surges ahead of a decision on its use as a weight-loss treatment, with shares soaring 18% to a record...
Eli Lilly and Company (LLY) - Yahoo Finance
Get the latest Eli Lilly and Company (LLY) stock news and headlines to help you in your trading and investing decisions.
Eli Lilly expects FDA call on Zepbound for sleep apnea in near term
Jun 21, 2024 · Key Points. Eli Lilly said it applied for U.S. approval of its weight loss drug Zepbound for the treatment of the most common sleep-related breathing disorder and expects regulators to make a...
Here’s why Eli Lilly bounced back, plus mega-caps lag while
4 days ago · Here’s why Eli Lilly bounced back, plus mega-caps lag while staples stocks rise. An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March 28 ...